Results 131 to 140 of about 664,100 (294)

Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo

, 1967
W. Robert Bruce, B. E. Meeker, Fred Valeriote   +2 more
openalex   +1 more source

Engineering Bacteria as Living Therapeutics in Cancer Therapy

Advanced Science, EarlyView.
Through synthetic biology approaches, natural bacteria can be genetically programmed into multifunctional living therapeutics. These engineered bacteria are capable of secreting anti‐tumor factors, displaying tumor‐associated antigens on their surface, or undergoing programmed self‐lysis to release therapeutic cargo.
Jiangfeng Chen, Jiaqi Chen, Yixuan Chen, Wenxuan Yuan, Jiao Zhang, Guoqing Wang, Zhuojun Dai   +6 more
wiley   +1 more source

Cellular Degeneration Associated with Characteristic Nuclear Fine Structural Changes in the Cells from two cases of Burkitt's Malignant Lymphoma Syndrome

, 1963
M. A. Epstein, Peter B. Herdson
openalex   +1 more source

Pleomorphic lymphoma and gastric adenocarcinoma (collision neoplasm) associated with monoclonal macroglobulinemia and amyloidosis:A case report [PDF]

, 1969
Antonio Coppola, Valentin Yermakov, Vincent Caggiano   +2 more
openalex   +1 more source

Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin‐mediated Phagocytic Effects for Lung Cancer Treatment

Advanced Science, EarlyView.
Repurposing cardiac glycosides (CGs) significantly strengthens the efficacy of anti‐CD47 antibody for lung cancer treatment by boosting macrophage phagocytosis. This novel combination blocks the “don't eat me” signal and increases dual “eat‐me” signals, Fc‐FcγR and cell surface expression of calreticulin (ecto‐CRT).
Zi‐Han Ye, Wei‐Bang Yu, Mu‐Yang Huang, Yan‐Yan Chen, Le‐Le Zhang, Chung‐Hang Leung, Xiao‐Lei Zhang, Zhenghai Tang, Ting Li, Jin‐Jian Lu   +9 more
wiley   +1 more source

Survival of mice bearing a transplanted syngeneic lymphoma following treatment with cyclophosphamide, 5-fluorouracil, or 1, 3-bis(2-chloroethyl)-1-nitrosourea

, 1968
W. Robert Bruce, Fred Valeriote, B. E. Meeker   +2 more
openalex   +1 more source

Immuno-gel diffusion studies with the herpes type virus (HTV) associated with burkitt's lymphoma [PDF]

, 1969
Mitsuri Konn, David S. Yohn, Yorio Hinuma, Junji Yamaguchi, James T. Grace   +4 more
openalex   +1 more source

Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions. [PDF]

Oncoscience
Tiwari B, Afshan R, Sridhar S.
europepmc   +1 more source

B‐EPIC: A Transformer‐Based Language Model for Decoding B Cell Immunodominance Patterns

Advanced Science, EarlyView.
B‐Epic: Achieving high‐accuracy B cell epitope prediction through Transformer architecture. Comprehensive validation demonstrates B‐Epic's robust performance across diverse datasets. B‐Epic facilitates vaccine development for H. pylori and EBV, addressing critical public health challenges.
Jun‐Ze Liang, Youtao Wang, Cong Sun, Tao Liu, Zengfeng Wu, Lipeng Chen, Lina Chen, Penglin Li, Zhengkang Li, Cangui Zhang, Bingyun Lu, Ye Chen, Bing Gu, Qian Zhong, Xin Wei Wang, Mu‐Sheng Zeng, Jinping Liu   +16 more
wiley   +1 more source

CYCLIC VARIATIONS IN THE H-2 ISOANTIGENIC EXPRESSION OF MOUSE LYMPHOMA CELLS IN VITRO

, 1969
Bertil Bjaring, George Klein, I Popp
openalex   +1 more source